Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Extends Compugen Relationship, Licenses Two Protein Analysis Programs

NEW YORK, July 23-Pfizer's global R&D division has extended a deal with Compugen and licensed the Israeli bioinformatics company's biological modeling program, called Leads, as well as two protein analysis software products, Z4000 and Z3.


Pfizer acquired its relationship with Compugen through its purchase of Warner-Lambert in 2000. Warner-Lambert's Parke-Davis division had begun a collaboration with Compugen in 1998.


A Compugen press release made no mention of money.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.